A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer

Tomohiro Kitahara; Ichiro Takemasa; Akira Inoue; Hideki Osawa; Masaaki Miyo; Yukako Mokutani; Hisataka Ogawa; Atsushi Naito; Atsushi Hamabe; Masayuki Hiraki; Koji Munakata; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Tsunekazu Mizushima; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori

A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer

Tomohiro Kitahara, Ichiro Takemasa, Akira Inoue, Hideki Osawa, Masaaki Miyo, Yukako Mokutani, Hisataka Ogawa, Atsushi Naito, Atsushi Hamabe, Masayuki Hiraki, Koji Munakata, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Tsunekazu Mizushima, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

抄録

A 70-year-old man presenting with melena was referred to our clinic. A clinical examination revealed a bulky tumor in the lower rectum. After ileostomy, 4 courses of capecitabine plus oxaliplatin (XELOX) therapy were administered as neoadjuvant chemotherapy. Computed tomography (CT) revealed significant reduction of the tumor. Laparoscopic super-low anterior resection with lateral lymph node dissection was performed. The pathological examination revealed no residual cancer cells, and a diagnosis of pathological complete response was made. The patient has been disease-free for 1 year after the operation. Neoadjuvant chemotherapy with XELOX might be promising for patients with locally advanced rectal cancer.

本文言語	英語
ページ（範囲）	1569-1571
ページ数	3
ジャーナル	Japanese Journal of Cancer and Chemotherapy
巻	41
号	12
出版ステータス	出版済み - 11月 2014
外部発表	はい

!!!All Science Journal Classification (ASJC) codes

腫瘍学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

他のファイルとリンク

引用スタイル

Kitahara, T., Takemasa, I., Inoue, A., Osawa, H., Miyo, M., Mokutani, Y., Ogawa, H., Naito, A., Hamabe, A., Hiraki, M., Munakata, K., Uemura, M., Nishimura, J., Hata, T., Mizushima, T., Yamamoto, H., Doki, Y., & Mori, M. (2014). A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer. Japanese Journal of Cancer and Chemotherapy, 41(12), 1569-1571.

Kitahara, T, Takemasa, I, Inoue, A, Osawa, H, Miyo, M, Mokutani, Y, Ogawa, H, Naito, A, Hamabe, A, Hiraki, M, Munakata, K, Uemura, M, Nishimura, J, Hata, T, Mizushima, T, Yamamoto, H, Doki, Y & Mori, M 2014, 'A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer', Japanese Journal of Cancer and Chemotherapy, vol. 41, no. 12, pp. 1569-1571.

@article{a88f38bb231e4d43acc6b04e9bec7c05,

title = "A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer",

abstract = "A 70-year-old man presenting with melena was referred to our clinic. A clinical examination revealed a bulky tumor in the lower rectum. After ileostomy, 4 courses of capecitabine plus oxaliplatin (XELOX) therapy were administered as neoadjuvant chemotherapy. Computed tomography (CT) revealed significant reduction of the tumor. Laparoscopic super-low anterior resection with lateral lymph node dissection was performed. The pathological examination revealed no residual cancer cells, and a diagnosis of pathological complete response was made. The patient has been disease-free for 1 year after the operation. Neoadjuvant chemotherapy with XELOX might be promising for patients with locally advanced rectal cancer.",

author = "Tomohiro Kitahara and Ichiro Takemasa and Akira Inoue and Hideki Osawa and Masaaki Miyo and Yukako Mokutani and Hisataka Ogawa and Atsushi Naito and Atsushi Hamabe and Masayuki Hiraki and Koji Munakata and Mamoru Uemura and Junichi Nishimura and Taishi Hata and Tsunekazu Mizushima and Hirofumi Yamamoto and Yuichiro Doki and Masaki Mori",

year = "2014",

month = nov,

language = "English",

volume = "41",

pages = "1569--1571",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "12",

}

TY - JOUR

T1 - A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer

AU - Kitahara, Tomohiro

AU - Takemasa, Ichiro

AU - Inoue, Akira

AU - Osawa, Hideki

AU - Miyo, Masaaki

AU - Mokutani, Yukako

AU - Ogawa, Hisataka

AU - Naito, Atsushi

AU - Hamabe, Atsushi

AU - Hiraki, Masayuki

AU - Munakata, Koji

AU - Uemura, Mamoru

AU - Nishimura, Junichi

AU - Hata, Taishi

AU - Mizushima, Tsunekazu

AU - Yamamoto, Hirofumi

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2014/11

Y1 - 2014/11

N2 - A 70-year-old man presenting with melena was referred to our clinic. A clinical examination revealed a bulky tumor in the lower rectum. After ileostomy, 4 courses of capecitabine plus oxaliplatin (XELOX) therapy were administered as neoadjuvant chemotherapy. Computed tomography (CT) revealed significant reduction of the tumor. Laparoscopic super-low anterior resection with lateral lymph node dissection was performed. The pathological examination revealed no residual cancer cells, and a diagnosis of pathological complete response was made. The patient has been disease-free for 1 year after the operation. Neoadjuvant chemotherapy with XELOX might be promising for patients with locally advanced rectal cancer.

AB - A 70-year-old man presenting with melena was referred to our clinic. A clinical examination revealed a bulky tumor in the lower rectum. After ileostomy, 4 courses of capecitabine plus oxaliplatin (XELOX) therapy were administered as neoadjuvant chemotherapy. Computed tomography (CT) revealed significant reduction of the tumor. Laparoscopic super-low anterior resection with lateral lymph node dissection was performed. The pathological examination revealed no residual cancer cells, and a diagnosis of pathological complete response was made. The patient has been disease-free for 1 year after the operation. Neoadjuvant chemotherapy with XELOX might be promising for patients with locally advanced rectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=84949238217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949238217&partnerID=8YFLogxK

M3 - Article

C2 - 25731255

AN - SCOPUS:84949238217

VL - 41

SP - 1569

EP - 1571

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -

A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer

抄録

!!!All Science Journal Classification (ASJC) codes

UN SDG

他のファイルとリンク

フィンガープリント

引用スタイル